SiSaf Ltd is an innovative drug delivery company focussed on the design and formulation of solid nanoparticles and their application in topical, sub lingual, and other dermal forms of drug delivery. SiSaf's proprietary technology is based on a novel synergistic drug delivery formula that uses nanoparticles to allow active compounds to penetrate deeper into the dermal layer, to target the cell membrane, and to be released in a controlled manner. SiSaf's technology has the potential to considerably enhance the safety and efficacy of proteins and peptides and labile or insoluble molecules.